Search

everythinglearnresearchcommunity

for

Search:↓

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Using focused ultrasound on the brain can help epilepsy medicine work better in rats.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

Valproic acid may cause hair loss by reducing biotinidase enzyme activity in rats.

Mefloquine was generally safe at 500 mg weekly, but higher doses caused nausea and diarrhea.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

The treatment was ineffective in humans.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Finasteride breakdown products found in bile and urine, helps understand drug safety and effectiveness.

IL-1 blockade is effective for treating SURF, and personalized treatment is needed.

The rash resolved after stopping ponatinib.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Relapsing hepatitis A can cause prolonged abnormal liver tests even without symptoms.

Flutamide helps with prostate cancer and some skin conditions but can harm the liver.

Tofacitinib effectively regrows hair in alopecia universalis triggered by a virus.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

OCT4B1 and SOX-2 levels are higher in Crohn's and ulcerative colitis patients, possibly aiding tissue repair.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

A woman developed Cushing syndrome and adrenal insufficiency from using fluticasone and ritonavir together.

Inclisiran is effective at lowering cholesterol.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

The new fluoroquinolone effectively fights certain bacteria.

Clofazimine may be effective for treating ashy dermatosis.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.